Anlet 75 mg (Tablet)

Unit Price: ৳ 11.00 (3 x 10: ৳ 330.00)
Strip Price: ৳ 110.00

Medicine Details

Indications

  • Reduction of myocardial infarction (MI) rate
  • Reduction of stroke rate
  • Treatment for non-ST-segment elevation ACS
  • Treatment for unstable angina (UA)
  • Treatment for non-ST-elevation myocardial infarction (NSTEMI)
  • Treatment for acute ST-elevation myocardial infarction (STEMI)
  • Prevention of recent MI
  • Prevention of recent stroke
  • Prevention of peripheral arterial disease
  • Reduction of bleeding risk
  • Antiplatelet effect

Pharmacology

  • Prodrug
  • Inhibition of platelet activation
  • Irreversible binding to P2Y12 receptors
  • Dose-dependent inhibition of platelet aggregation
  • Onset of action within 2 hours
  • Steady state inhibition between Day 3 and Day 7

Dosage & Administration

  • Loading dose of 300 mg (4 tablets)
  • Maintenance dose of 75 mg once daily
  • Oral administration
  • Fast antiplatelet effect when initiated with a loading dose

Interaction

  • Increased risk of bleeding with NSAIDs, warfarin, SSRIs, SNRIs
  • Avoid concomitant use with CYP2C19 inhibitors like omeprazole or esomeprazole
  • Increased plasma concentrations of Repaglinide when used concomitantly

Contraindications

  • Hypersensitivity to the drug substance or any component
  • Active pathological bleeding such as peptic ulcer or intracranial hemorrhage

Side Effects

  • Common: Bleeding, Diarrhoea, gastrointestinal discomfort, haemorrhage, Skin reactions
  • Rare: Acquired haemophilia, anaemia, angioedema, arthralgia, arthritis, bone marrow disorders

Pregnancy & Lactation

  • Use during pregnancy only if clearly needed
  • Unknown excretion in human breast milk
  • Decision making for breastfeeding mothers

Precautions & Warnings

  • Metabolism impairment in CYP2C19 poor metabolizer
  • Risk of bleeding due to lifelong platelet aggregation inhibition
  • Increased risk of cardiovascular events after discontinuation
  • Reported cases of Thrombotic Thrombocytopenic Purpura (TTP)
  • Reported cases of hypersensitivity reactions

Use in Special Populations

  • Safety and effectiveness not established in pediatric populations
  • No dosage adjustment necessary in elderly patients

Overdose Effects

  • May lead to bleeding complications
  • Potential restoration of clotting ability with platelet transfusion

Therapeutic Class

  • Anti-platelet drugs

Storage Conditions

  • Keep below 30°C temperature
  • Store in a dry place
  • Protected from light
  • Avoid freezing
  • Keep out of reach of children

Related Brands